LIQUID BIOPSY IN 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer

    loading  Checking for direct PDF access through Ovid

Abstract

The challenge to obtain needle biopsy samples from patients with cancer has steered the development of new blood-based diagnostics called ‘liquid biopsy’. In 2016, major advances have been made in the use of circulating tumour cells and cell-free DNA for monitoring tumour evolution in patients with cancer of the gastrointestinal tract, with a focus on colorectal cancer.

Related Topics

    loading  Loading Related Articles